Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr18.80 SEK
Change Today -0.10 / -0.53%
Volume 83.6K
As of 11:30 AM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - oasmia pharmaceutical ab (OASM)

NameBoard RelationshipsTitleAge
Julian Aleksov 6 RelationshipsCo-Founder, Chief Executive Officer and Director49
Anders Lundin No RelationshipsChief Financial Officer and Acting Head of Information50
Mikael Asp No RelationshipsHead of Quality Assurance52
Anders Blom No RelationshipsExecutive Vice President45
John T. Cosby No RelationshipsHead of Regulatory Affairs52

Board Members - oasmia pharmaceutical ab (OASM)

NameBoard RelationshipsPrimary CompanyAge
Joel Tomas Citron 27 RelationshipsTenth Avenue Holdings, LLC52
Julian Aleksov 6 RelationshipsOasmia Pharmaceutical AB (publ)49
Hans Sundin 6 RelationshipsOasmia Pharmaceutical AB (publ)69
Bo Cederstrand 6 RelationshipsAlceco International S.A.75
Horst Domdey 8 RelationshipsBioM AG63

Executive Committees* - oasmia pharmaceutical ab (OASM)

Committee NameChairpersonBoard RelationshipsMembers
Nominating CommitteeBo Cederstrand 6 Relationships3 Executives
View OASM Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OASM:SS kr18.80 SEK -0.10

OASM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OASM.
View Industry Companies

Industry Analysis


Industry Average

Valuation OASM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 74.8x
Price/Book 4.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 70.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OASMIA PHARMACEUTICAL AB, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at